These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice. Lee B; Robinson KM; McHugh KJ; Scheller EV; Mandalapu S; Chen C; Di YP; Clay ME; Enelow RI; Dubin PJ; Alcorn JF Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L158-67. PubMed ID: 26001778 [TBL] [Abstract][Full Text] [Related]
3. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A mBio; 2016 May; 7(3):. PubMed ID: 27143388 [TBL] [Abstract][Full Text] [Related]
4. Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens. Parker D J Infect Dis; 2017 Feb; 215(suppl_1):S58-S63. PubMed ID: 28375519 [TBL] [Abstract][Full Text] [Related]
5. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission. Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN mBio; 2021 Feb; 12(1):. PubMed ID: 33593970 [TBL] [Abstract][Full Text] [Related]
13. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. Parker D; Martin FJ; Soong G; Harfenist BS; Aguilar JL; Ratner AJ; Fitzgerald KA; Schindler C; Prince A mBio; 2011; 2(3):e00016-11. PubMed ID: 21586648 [TBL] [Abstract][Full Text] [Related]
14. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852 [TBL] [Abstract][Full Text] [Related]
16. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. Li K; Chen Z; Kato N; Gale M; Lemon SM J Biol Chem; 2005 Apr; 280(17):16739-47. PubMed ID: 15737993 [TBL] [Abstract][Full Text] [Related]
17. RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism. Ma B; Dela Cruz CS; Hartl D; Kang MJ; Takyar S; Homer RJ; Lee CG; Elias JA Am J Respir Crit Care Med; 2011 May; 183(10):1322-35. PubMed ID: 21278304 [TBL] [Abstract][Full Text] [Related]
18. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Yarilina A; DiCarlo E; Ivashkiv LB J Immunol; 2007 Feb; 178(4):2204-11. PubMed ID: 17277125 [TBL] [Abstract][Full Text] [Related]
19. Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages. Mazaleuskaya L; Veltrop R; Ikpeze N; Martin-Garcia J; Navas-Martin S Viruses; 2012 May; 4(5):901-23. PubMed ID: 22754655 [TBL] [Abstract][Full Text] [Related]
20. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection. Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN mBio; 2019 May; 10(3):. PubMed ID: 31064834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]